Introduction

T
here has been an explosion of reports on human stem cells isolated from a variety of sources including embryonic, fetal, and adult tissues over the last 10 years. Mesenchymal stem cells (MSCs) can be found in various adult tissues and may contribute to tissue repair or regeneration. Compared with stem cells from the embryo or fetus, adult MSCs are easy to obtain and handle. Moreover, MSCs are suggested to be immunoprivileged, such that allogeneic MSCs can be transplanted when necessary.
Bone marrow (BM) has been extensively investigated as a source of adult stem cells. Because MSCs are multipotent and readily expandable in vitro, these cells have already been employed in early clinical studies, including the treatment of human myocardial infarction, osteogenesis imperfecta, and graft versus host disease [1] [2] [3] [4] . However, MSCs constitute only a small proportion of the cells in BM (0.01-0.001% of nucleated cells) and their number, frequency and differentiation capacity correlate inversely with age.
Subsequently, MSCs from other tissues having a similar immunophenotype have been isolated and investigated.
Adipose tissue (AT) is emerging as a source of stem cells that can be obtained by a less invasive method and in larger quantities than from BM. These cells can be isolated from human lipoaspirates and, like MSCs, can differentiate toward osteogenic, adipogenic, myogenic, chondrogenic, and especially neurogenic lineages [5] .
Several groups have demonstrated that the cells derived from cartilage meet the criteria for MSCs, including high rates of proliferation, clonogenicity, multipotentiality, and MSC marker phenotype. These cells were called "cartilagederived stromal cells" [6] , "dedifferentiated chondrocytes" [7] , and "articular-derived dedifferentiated chondrocytes (ADDCs)" [8] . We name these cells as cartilage-derived MSCs in our study.
When these MSCs were considered for potential therapeutic applications, various mechanisms for improving regeneration and functional repair were proposed. In addition to the effects caused by possible differentiation of these cells, one of the potential mechanisms for functional improvement in ischemic regions is the promotion of angiogenesis by means of the production of angiogenic cytokines [9, 10] . Therefore, the expression level of angiogenic cytokines by these cells assessed in vitro may re ect their potential in angiogenesis.
The survival capacity of MSCs in host tissues in conditions of ischemia or ischemic reperfusion is another important property to be considered. The use of an MSC graft approach is limited by the fact that most of the transplanted MSCs are readily lost, potentially triggered by the ischemic or ischemia-reperfusion environment in vivo [11, 12] . In our study, we investigated the anti-apoptosis ability of these MSCs toward oxidative stress induced by hydrogen peroxide (H 2 O 2 ) or serum deprivation.
The aim of this study was to compare MSCs from BM, cartilage, and AT for their immunophenotype characterization, proliferation capacity, potential for multi-lineage differentiation, expression of angiogenic cytokines, and resistance to apoptosis.
Materials and Methods
Isolation and culture of BM-MSCs, C-MSCs, and AT-MSCs
MSC cells were harvested from 3-week-old male SD rats killed by cervical dislocation. Rats were obtained from the Beijing Animal Administration Center and the animal experiments were approved by the Animal Care and Use Committee of Peking University. Limb bones, articular cartilage, and AT from the inguinal groove were isolated and washed extensively with excess volumes of phosphate-buffered saline (PBS) to remove blood cells.
BM was harvested by ushing the tibial and femoral marrow cavities with PBS and cultured as described elsewhere [13] . The articular cartilage and AT were separately digested with 0.2% collagenase II (Sigma) with intermittent shaking at 37°C for 2 h and 0.1% collagenase I (Sigma) at 37°C for 30 min. Enzyme activity was terminated by dilution with Dulbecco's Modi ed Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS) (HyClone, Logan, UT, USA). The oating cells were separated from the mesenchymal cell fraction by centrifugation (150g) for 5 min. The pellets were resuspended in normal culture medium (DMEM, 10% FBS, and 100 U/ml penicillin/streptomycin) and ltered through a 200 µm nylon mesh to remove undigested tissue.
The primary cells were cultured in 9 cm 2 falcon culture plates for 4-5 days until they reached con uence and were de ned as passage 0. The cells were passaged at a ratio of 1: 3. The cells used in subsequent experiments were between passage 3 and 6.
Immunophenotypic analysis
BM-MSCs, C-MSCs, and AT-MSCs at passages 3 and 6 were trypsinized into single cell suspension and stained with uorescein (FITC)-labeled antibodies including antirat CD34, CD45, CD44, and CD90 (Becton Dickinson) for ow cytometric analysis. Nonspeci c anti-rat IgG-FITC was used as an isotype control. CD73 was examined by indirect immuno uorescence. The rst antibody was mouse antirat CD73 (Becton Dickinson), and the secondary antibody was goat anti-mouse-FITC (Zhongshan Biochemical, China). Isotype control was established by eliminating the secondary antibody.
Proliferation characteristics
Growth curves. BM-MSCs, C-MSCs, and AT-MSCs at passage 3 were seeded in a 24-well plate with 1 × 10 4 cells per well in triplicate. Cells were collected from each well 1-7 days after seeding and counted microscopically to produce cell growth curves.
Cell cycle analysis. BM-MSCs, C-MSCs, and AT-MSCs at passages 3 and 6 (n = 5 each) were harvested respectively by trypsinization (0.25% trypsin-EDTA) and xed in 70% cold ethanol, stored at 4°C and treated with 1 mg/ml RNase (TaKaRa, Japan) for 30 min at 37°C. DNA was labeled with 20 µg/ml propidium iodide (PI, Sigma) in the dark for 30 min at 4°C and DNA content was assessed by ow cytometry Calibur (Becton Dickinson) using the ModiFit LT v2.0 software. Each group was analyzed in triplicate.
Telomerase activity. The telomerase activity of BM-MSCs, C-MSCs, and AT-MSCs at passages 3 and 6 (n = 5 each) was detected using the telomeric repeat ampli cation protocol (TRAP) assay (Roche, Germany).
Induction of multilineage differentiation
In vitro differentiation was performed at passages 3 and 6 for all three cell sources. For osteogenic and adipogenic induction, cells were seeded at 2 × 10 5 cells/well in 6-well plates and each group was analyzed in triplicate. The control groups were cultured with normal culture medium. Chondrogenic induction was performed differently.
Osteogenic differentiation. When they reached 80-90% conuence, BM-MSCs, AT-MSCs, and C-MSCs were induced to osteogenic differentiation with osteogenic culture medium (DMEM, 10% FBS, 10 mM-glycerophosphate, 0.01 μM 1,25-dihydroxyvitamin D3, 50 μM ascorbate-2-phosphate, and 100 U/ml penicillin/streptomycin) for de ned time points.
The expressions of osteogenic markers Runx 2, collagen I (COL I) and osteocalcin (OCN) were assessed by real-time RT-PCR at 1, 3, 7, 10, and 14 days after induction. Osteogenic differentiation was also con rmed by alkaline phosphatase (ALP) expression by histochemical staining and ALP activity analysis. ALP activity was measured with the ALP assay kit (Zhongsheng Biochemical, Beijing, China) at 0, 3, 7, 10, and 14 days. The results were normalized against the protein concentration and expressed as U/g/min.
Adipogenic differentiation. When they reached 80-90% con uence, BM-MSCs, AT-MSCs, and C-MSCs were induced to adipogenic differentiation with adipogenic induction medium (DMEM, 10% FBS , 1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methyl-xanthine, 10 μg/ml recombinant human insulin and 100 U/ml penicillin/streptomycin) for 7 days.
The expressions of peroxisome proliferator activated receptor γ (PPARγ) and lipoprotein lipase (LPL) were analyzed at 0, 3, and 7 days after induction by real-time RT-PCR. Adipogenic differentiation was con rmed by the formation of neutral lipid-vacuoles stainable with Oil Red O (Sigma-Aldrich) [14] . In brief, MSCs at day 7 after induction were xed with 4% paraformaldehyde, washed and stained with 0.18% Oil Red O for 5 min. The nuclei were counterstained with hematine solution. The proportion of adipogenic differentiation was evaluated by measuring the average photodensity of Oil Red O staining areas to the total area occupied by cells with a Leica Q550 CW microscope and Qwin image acquisition software.
Chondrogenic differentiation. BM-MSCs, AT-MSCs, and C-MSCs at passages 3 and 6 were induced to chondrogenesis. Centrifugation of 2.5 × 10 5 cells was done at 200g for 5 min in a 15 ml polypropylene tube. There were two groups in this study: one group was cultured in chondrogenic differentiation medium containing 10 ng/ml TGF-β1 (Peprotech, USA), 6.25 g/ml insulin, 1% antibiotic/ antimycotic, and the control group was cultured with normal medium (DMEM, 10% FBS).
Cell pellets were harvested in Trizol reagent for the isolation of mRNA at 0, 7, and 14 days after induction. The expression of collagen II (COL II), aggrecan, and bromodulin (Fmod) was assessed by real-time RT-PCR.
Fourteen days after induction, the cell pellets were xed with 4% paraformaldehyde, embedded in paraf n and cut into 5 μm sections [15] . Sections were stained with 1% toluidine blue (Sigma, USA) at pH 2.5 for 30 min and rinsed with tap water. Morphometric analysis of images in histological sections was carried out with an Olympus IX-70 microscope (Tokyo, Japan).
COL II expression was examined by indirect immuno uorescence. After antigen repair and 5% goat serum blocking, the sections were incubated with a polyclonal antibody against COL II (Santa Cruz Biotechnology), followed by antigoat FITC-conjugated antibody (Zhongshan Biochemical, China) at a dilution of 1:200. After rinsing three times with PBS, sections were visualized by uorescence confocal microscopy.
Quantitative real-time RT-PCR
Total RNA of BM-MSCs, AT-MSCs, and C-MSCs (n = 3 each, repeated at least three times) was extracted with Trizol reagent (Life Technologies) and quanti ed by ultraviolet spectroscopy at assigned time points post-induction. cDNA synthesis was performed using total RNA (1 μg) as a template by oligo(dT) priming using the Superscript First Strand Synthesis System for RT-PCR (Invitrogen). Real-time RT-PCR was performed with an optional continuous uorescence detection system (MJ research, MA); 1 μl of reverse transcribed product and 1× SYBR green (Molecular Probes, Eugene, OR) were included in 25 μl reaction mixture (10 mM Tris-HCL, pH 8.3, 50 mM KCL, 1.5 mM MgCl 2 , 200 μM of dNTP mix, 0.2 μM of each primer and 1 unit of Taq DNA polymerase). Real-time RT-PCR oligonucleotide primers were designed using Oligo 6 primer analysis software. PCR primers were as follows (5′-3′): Runx-2: Fw AACCC ACGAATGCACTATCCA, Rev CTTCCATCAGCGTCAAC ACCA; COL I: Fw GGAGAGAGTGCCAACTCCAG, Rev . Levels of mRNA were normalized against GAPDH using the comparative cycle threshold (CT) method. PCR primers for GAPDH (5′-3′) were: Fw GAAAAGCTGTGGC GTGATGG-3, Rev GTAGGCCATGAGGTCCACCA. Serum deprivation-induced apoptosis. BM-MSCs, AT-MSCs, and C-MSCs at passage 3 were seeded at 2 × 10 3 cells per well in a 96-well plate and then subjected to 24 to 72 h exposure to serum free medium. Apoptosis was detected by MTT and ow cytometry analysis (as described above). The MTT method is based on the ability of living cells to reduce MTT tetrazolium salt to MTT formazan with the mitochondrial enzyme succinate-dehydrogenase. Brie y, cells were incubated for 2 h with MTT solution (0.5 mg/ml PBS) and MTT formazan was then extracted in DMSO. Measurement of optical density was performed at 560 nm with a microplate reader. The optical density of the control (cell culture without any treatment) corresponds to 100% MTT reduction. Results were expressed as a percentage of the control and data were presented as mean values ± SD (n = 3).
Apoptosis induction and detection
Statistical analysis
All experiments were repeated a minimum of three times. Data are presented as mean ± SD. The One-Way
Multilineage differentiation potential
We investigated the potential of BM-MSCs, C-MSCs, and AT-MSCs to differentiate toward osteogenic, adipogenic and chondrogenic lineages.
Osteogenic differentiation capacity. ALP staining showed that the three types of MSC all possessed the capacity for osteogenic differentiation 2 weeks after induction ( Fig. 2A) . No ALP aggregates were observed in control groups (not shown).
The expression of osteogenic genes was assessed at 1, 3, 7, 10, and 14 days after induction by real-time RT-PCR. The genes included Runx 2, a transcription factor at the downstream end of bone morphogenetic protein (BMP) signaling pathways, collagen I (COL I), and OCN, an extracellular matrix protein and a marker of mature osteoblasts. Upregulated mRNA expression of all three osteogenic genes was observed in induced MSCs but with different patterns. Generally, upregulation of all these genes peaked at 3 or 7 days in BM-MSCs, well ahead of AT-MSCs and C-MSCs ( Fig. 2B-D) .
Moreover, the ALP activity assay showed that BM-MSCs possess higher ALP activity than the other MSCs. The ALP activity of BM-MSCs markedly increased at days 10 and 14, and remained at a higher level than C-MSCs and AT-MSCs thereafter. There was no signi cant difference between the AT-MSC and C-MSC groups (Fig. 2E) .
Adipogenic differentiation capacity. Adipogenic differentiation was demonstrated by the accumulation of neutral lipid vacuoles indicated by the Oil Red O stain (Fig. 3A) . No red staining was detected in control groups (not shown).
The expressions of PPARγ and LPL were analyzed at 0, 3, and 7 days after induction by real-time RT-PCR. PPARγ, a lipocyte-speci c transcription factor, and LPL, a lipid exchange enzyme, were upregulated during adipogenesis. The basic expressions of PPARγ and LPL were initially detected in AT-MSCs and their expression levels reached a peak at day 3 after induction. At the same time, compared with BM-MSCs, the expressions dramatically increased in C-MSCs and reached a peak at day 3 (Fig. 3B) .
In order to quantify the ratio of lipogenic differentiation, additional slides stained with Oil Red O 7 days after induction were prepared for densitometric analysis. The ratio of red staining area to the total area of cells was significantly higher in C-MSC and AT-MSC samples than that of BM-MSCs (p < 0.01) (Fig. 3C) .
Chondrogenic differentiation capacity. Compared with control groups, chondrogenic differentiation of BM-, C-and AT-MSCs was con rmed by the formation of sphere-like pellets and the secretion of cartilage-speci c proteoglycans stainable with toluidine blue. Specially, C-MSCs were able to form pellets that stained more intensely with toluidine blue, not only in the induction groups but also in the noninduction groups (Fig. 4A) .
COL II and aggrecan mRNA reached a maximum at about 7 days in C-MSCs, whereas mRNA levels increased up to 14 days in BM-MSCs and AT-MSCs. Fibromodulin (Fmod) levels exhibited a time-dependent increase up to 2 weeks after induction in all three type of cells (Fig. 4B) .
ANOVA test was used to analyze results of ow cytometry, real-time RT-PCR, MTT and comparison of multilineage induction at different time points. Differences between the experimental and control groups were regarded as statistically signi cant when p < 0.05. The SPSS software package (version 13.0; SPSS Inc., USA) was used for the statistical tests.
Results
Isolation and proliferation characteristics of BM-MSCs, C-MSCs, and AT-MSCs
Cells isolated from limb bones, articular cartilage, and AT were initially plated in 9-cm 2 falcon culture plates. After 3-4 days culture, 6-10 cell colonies were observed in the BM-MSC and C-MSC plates, whereas AT-MSCs reached 100% con uence.
There were mixtures of cells at the original passage. During passaging to the third generation, cells derived from the three different sources became more uniform and grew in a monolayer with typical broblast morphology. BM-MSCs were larger than the others morphologically (Fig. 1A) .
To further characterize these cells, cell surface markers were examined by ow cytometry. MSCs from all three sources were negative for the hematopoietic lineage markers CD34 and CD45, indicating that they were of non-hematopoietic origin. The percentage of CD44 positive cells in BM-, C-and AT-MSCs was 94.16%, 95% and 98.4%; CD73 was 84.07%, 60.63% and 96.98%; and CD90 (Thy-1) was 93.38%, 61.91% and 95.61%, respectively (Fig. 1B) .
Expansion characteristics
Among the three sources of MSCs, AT-MSCs grew at the highest speed and kept almost the same growth speed throughout ten generations whereas C-MSCs showed replicative senescence as indicated by a loss of proliferation after the eighth generation. Compared with AT-and C-MSCs, BM-MSCs appeared to grow at a relatively slow but constant speed until the tenth generation. The population doubling time of BM-MSCs, C-MSCs, and AT-MSCs was 61.2, 51.47, and 45.2 h, respectively, based on the logarithmic growth phase. AT-MSCs possessed the lowest population doubling numbers at passages 3. BM-MSCs reached 100% con uence in 5 days, partly because the area of a single BM-MSC is larger than that of C-MSC or AT-MSC (Fig. 1C) .
Flow cytometric analysis of the cell cycle showed different percentages of cell populations in each phase. The results indicated that AT-MSCs possessed the greatest proliferation capacity with the highest proportion in S phase, followed by BM-MSCs and C-MSCs (Fig. 1D) . G1, G2/M, S proportions of MSCs at passage 3 and 6, respectively, are shown in Table 1 . Signi cant differences in S phase were observed among the three MSC types (*p < 0.05).
The telomerase activity results indicated differences among BM-MSCs, AT-MSCs and C-MSCs at the same passage. There was no signi cant difference between passage 3 and passage 6 for the same type of cell (Fig. 1E) . A high level of COL II expression was also observed after chondrogenic induction of C-MSCs using confocal microscopy after immuno uorescent staining. In the control group, though no mature chondrocytes were shown in the C-MSC group, the intensity of COL II green uorescence was signicantly higher than in the parallel control groups of BM-MSCs and AT-MSCs (Fig. 4C) .
Angiogenic cytokine expressions detected by real-time RT-PCR
The expression levels of various angiogenesis factors in BM-, C-, and AT-MSCs at passages 3 and 6 were measured by real-time RT-PCR. These factors included the following: vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF), hepatocyte growth factor (HGF), basic broblast growth factor (bFGF), transforming growth factor-β1 (TGF -β1), angiopoetin-1 (Ang-1), and stem cell factor (SCF).
The results indicated basic expression of those angiogenic cytokines in original culture and varied from passage 3 to passage 6. In general, expression levels of these factors were higher in passage 3 than in passage 6. The expressions of VEGF (Fig. 5A) and IGF (Fig. 5B) were higher in BM-MSCs than other types of MSCs, whereas PDGF (Fig. 5C) and HGF (Fig. 5D) were highest in C-MSCs. The expression of bFGF (Fig. 5E ) in AT-MSCs showed an incredibly high level at passage 3, which decreased dramatically by passage 6. Moreover, TGF-β1 exhibited lower level expression in C-MSCs than BM-MSCs and AT-MSCs (Fig. 5F ). Ang-1, a strong angiogenesis factor, was expressed at a relatively high level at passage 3 of all three types of MSCs but decreased at passage 6 (Fig. 5G) . High level expression of SCF was observed in BM-MSCs at passage 3 but not in C-MSCs and AT-MSCs (Fig. 5H) .
Anti-apoptosis ability
Apoptosis triggered by 2 mmol/L H 2 O 2 . After 90 min of 2 mmol/L H 2 O 2 induction, obvious morphology changes in the BM-MSCs, C-MSCs, and AT-MSCs were observed by light microscopy. AT-MSCs showed the most sensitive reaction to oxidative stress in that most of cells detached from the plate. In contrast to AT-MSCs and BM-MSCs, C-MSCs showed superior tolerance to oxidative stress with the least morphological change. Apoptosis was con rmed through confocal microscopy using Tunel staining (Fig. 6A) and Annexin-V and PI double staining (Fig. 6B ).
Quantitative analysis of apoptosis was also conducted by FACS and con rmed that C-MSCs possessed the highest tolerance to oxidative stress, followed by BM-MSCs (Fig. 6C) . Signi cant differences were observed among the three kinds of MSCs (Fig. 6D) .
Apoptosis induced by serum deprivation. To evaluate the survivability of MSCs from the three different sources in response to serum-free culture, cells were analyzed by MTT. Within 60 h, proliferation ability was inhibited to different extents and the morphology of cells had changed. C-MSCs showed inferior tolerance to serum-free culture than the other MSCs (Fig. 6E) .
At 60 h after induction of serum deprivation, BM-MSCs, C-MSCs, and AT-MSCs were stained with Annexin-V and PI and assessed by FACS. The ratio of apoptosis was consistent with the result of MTT. BM-MSCs and AT-MSCs have superior anti-apoptosis capacity toward serum-free culture ( Fig. 6F and G) .
We summarize our observations in Table 2 .
Discussion
Transplantation of autologous or allogeneic MSCs represents a novel form of stem cell therapy which shows substantial promise in the treatment of a number of human diseases. In order to provide a foundation for further biological characterization, we analyzed MSCs from rat BM and two alternative sources, cartilage and AT. As potential seed cells for stem cell transplantation, their ease of isolation, survival ability and expansion potential, capacity for differentiation, and potential to enhance repair in vital tissues are among their most important properties [5, 16, 17] . This study, to our knowledge, presents for the rst time a systematical and all-round comparison of MSCs from BM, cartilage, and AT for the purpose of setting up an experimental evaluation system to help choose a better cell source for further clinical therapies. Our observations could provide some experimental evidences on choosing a suitable cell source for a particular therapeutic purpose.
Our ndings indicate that: (1) AT-MSCs are a promising source due to their high proliferation ability; (2) C-MSCs possess superior capacity toward chondrogenic differentiation and therefore might be a good seed cell source for cartilage tissue engineering; (3) MSCs from BM, cartilage, and AT all express angiogenic cytokines; (4) C-MSCs possess the highest resistance toward H 2 O 2 -induced apoptosis, while AT-MSCs exhibit high tolerance to serum deprivationinduced apoptosis. The table shows the mean values of the percentage of cells at each phase (mean ± standard deviation). Signi cant differences in S phase were observed between every two groups (*p < 0.05). A promising alternative source to BM-MSCs, MSCs from human AT can be obtained by a less invasive method and harvested in larger quantities than from other sources [5, 18] . According to the growth curve analysis, the population doubling time of AT-MSCs is 45.2 h, signi cantly shorter than BM-MSCs (61.2 h), and C-MSCs (51.47 h). The percentage of AT-MSCs in S phase was 26.22 ± 2.67 % at passage 3 and 19.66 ± 0.94 h at passage 6, indicating that AT-MSCs possess high self-propagating potential, which was veri ed by their high telomerase activity.
BM-MSCs
Human cartilage has been reported to contain multipotent stem cells that possess functional capacity both for self-renewal and multipotential differentiation [7, 8] . In our research, we harvested a population of stem cells from rat the fact that non-differentiated MSCs expressed multiple osteogenic, adipogenic, and chondrogenic genes as shown by the results of real-time RT-PCR. However, our investigations were limited to studying mesodermal differentiation. The spectrum of differentiation of MSCs does not seem to be restricted to these lineages. MSCs derived from BM and AT have been shown to differentiate into other mesodermal lineages and into endo-and ectodermal lineages as well [20] [21] [22] .
How did MSCs affect repair and regeneration? In animal models of cardiac ischemia, a large body of evidence indicates that administration of angiogenic cytokines can augment reperfusion and enhance neovascularization through paracrine mechanisms. Several growth factors have angiogenic activity, such as VEGF, bFGF, PDGF, HGF, IGF, TGF, and Ang-1 [13, [23] [24] [25] . SCF was considered to conduct the mobilization of BM stem cells [26] . However, the basic expression of angiogenic cytokines was not clear. We compared the expression of angiogenic cytokines in BM-, C-, and AT-MSCs at different passages under normal growth conditions by quantitative RT-PCR. The results demonstrated that expression levels of angiogenesis factors differed among cartilage, which proved to have self-renewal and mesodermal differentiation capacity. Furthermore, this population of cells was negative for CD34 and CD45, and positive for CD44, CD73 and CD90. These results are similar to those of previous reports [18, 19] .
Multi-lineage differentiation potential has been considered an important quality of stem cells. In the present study, MSCs from BM, cartilage, and AT were veri ed to possess osteogenic, adipogenic, and chondrogenic potential. Meanwhile, the differences in differentiation propensity illustrated that the capacity for differentiation should be evaluated. Depending on the expression of lineage-speci c markers, BM-MSCs exhibited superior capacity to osteogenic differentiation but inferior capacity to adipogenic differentiation. Compared with BM-and AT-MSCs, C-MSCs have the greatest potential for chondrogenesis based on the formation of cartilage matrix and the expression of COL II, indicating that C-MSCs may be a good cell source for cartilage tissue engineering.
Why do such differences exist? One possibility is that MSCs are composed of different types of precursor cells rather than having a pure cell population [5] . This is supported by Another aspect we considered an important property for seed cells is survival capacity. To imitate conditions in vivo, MSCs was exposed to superoxide stress and serum deprivation. Surprisingly, C-MSCs were found to possess superior anti-apoptotic ability under H 2 O 2 conditions but inferior survival ability toward serum deprivation. AT-MSCs showed the opposite, with higher sensitivity to superoxide stress, which usually accompanies ischemia-reperfusion damage. These results indicate that the optimal method for and timing of cell transplantation needs to be considered with a view to the potential clinical application. The ndings that MSCs from different sources behave differently toward H 2 O 2 -induced or serum deprivation-induced apoptosis are extremely interesting. Some studies indicated that serum deprivation-induced apoptosis in MSCs occurred through the mitochondrial apoptotic pathway by inducing Bax protein translocation to the mitochondria, loss of ∆ψm, release of cytochrome c, and activation of caspase cascades, but in a p53-independent manner [11] .While the mechanism of H 2 O 2 -induced apoptosis in MSCs is still not well understood. It was reported that H 2 O 2 -induced apoptosis in neural cells was mediated by p53 pathway [27] . If this mechanism is also involved in MSCs, the different behavior of the three sources of MSCs toward oxidative stress and serum deprivation might be explained. To fully elucidate the mechanisms, further studies are needed.
Taking into account the advantages and disadvantages of the three stem cell sources discussed above, clinical applications may be based on their differentiation capacity, but more likely on the abundance, frequency, and expansion potential of the cells. AT-MSCs could be a good resource as an alternative to BM-MSCs, and C-MSCs might be a good candidate for cartilage tissue engineering. The table shows the comparative results of MSCs from BM, C, and AT. Signi cant differences were shown as "+++" "++" and "+." "+++" shows the highest ability among the three kinds of MSCs; "++" shows moderate ability;"+" shows the least ability. *The basal expressions of different angiogenic cytokines were varied in greater degrees and thus we did not attempt to make a general rating. **SD stands for serum deprivation.
